Sam L. Barker

This profile gathers the share dealings of Sam L. Barker across 4 companies, led by Lexicon Pharmaceuticals, Inc., Cadence Pharmaceuticals Inc and Bio Green Med Solution, Inc. Over a trading history stretching from 25 January 2008 to 3 June 2026, the count stands at 53 filings.

Market trades split into 31 purchases (€205k) and 3 sales (€761). The net balance comes to €204k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 10 share grants and 8 option exercises.

A typical purchase (the median) is worth €4,254. 3 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 4 June 2026 came the latest disclosure, an option exercise in Lexicon Pharmaceuticals, Inc. The clock since the last published purchase (25 August 2021) now reads 1,886 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.